Tools · Private company
BioPorto Diagnostics
Track this companyFree. Adds BioPorto Diagnostics to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ProNephro AKI™ (NGAL)Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- ProNephro NGAL Test for Early Detection of Acute Kidney Injury in Adult ICU Patients (ALPACA)ENROLLING_BY_INVITATION · started Jul 21, 2026ClinicalTrials.gov NCT07751913 · fetched Nov 12, 2026
- Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in AdultsACTIVE_NOT_RECRUITING · started Oct 28, 2024ClinicalTrials.gov NCT06652100 · fetched Nov 12, 2026